Nuveen
ANRO icon

Nuveen’s Alto Neuroscience ANRO Stock Holding History

Nuveen’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
+62,342
New +$1.44M ﹤0.01% 2680
2025
Q2 		– Sell
-139,953
Closed -$302K – 3430
2025
Q1 		$302K Hold
139,953
– – ﹤0.01% 3042
2024
Q4 		$592K Sell
139,953
-61,310
-30% -$383K ﹤0.01% 2927
2024
Q3 		$2.3M Buy
201,263
+163,564
+434% +$2M ﹤0.01% 2341
2024
Q2 		$403K Buy
+37,699
New +$491K ﹤0.01% 3061

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Nuveen's ANRO Position: Q2 2026 in Review

Nuveen opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 62,342 shares worth $1.65M. The stake represents ﹤0.01% of the portfolio and ranks #2680 among its holdings. This is a return to the name: Nuveen previously reported a position in ANRO as recently as Q1 2025.

Nuveen first reported a position in ANRO in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.3M in Q3 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Nuveen held 62,342 shares of Alto Neuroscience worth $1.65M as of Q2 2026.
  • Alto Neuroscience was a new Nuveen position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2680 holding.
  • Nuveen first reported a position in Alto Neuroscience in Q2 2024 and has held it in 5 quarters since.
  • Nuveen's Alto Neuroscience position peaked at $2.3M in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.